Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGND) Tax Rate: 2011-2025

Historic Tax Rate for Ligand Pharmaceuticals (LGND) over the last 10 years, with Sep 2025 value amounting to 16.91%.

  • Ligand Pharmaceuticals' Tax Rate was N/A to 16.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.86%, marking a year-over-year decrease of 21.00%. This contributed to the annual value of 15.46% for FY2023, which is N/A change from last year.
  • As of Q3 2025, Ligand Pharmaceuticals' Tax Rate stood at 16.91%, which was down 70.24% from 56.81% recorded in Q2 2025.
  • In the past 5 years, Ligand Pharmaceuticals' Tax Rate registered a high of 56.81% during Q2 2025, and its lowest value of 7.74% during Q2 2021.
  • Its 3-year average for Tax Rate is 24.35%, with a median of 20.69% in 2024.
  • Per our database at Business Quant, Ligand Pharmaceuticals' Tax Rate plummeted by 3,223bps in 2021 and then skyrocketed by 3,620bps in 2025.
  • Ligand Pharmaceuticals' Tax Rate (Quarterly) stood at 22.83% in 2021, then soared by 1,186bps to 21.93% in 2022, then slumped by 652bps to 15.41% in 2023, then plummeted by 717bps to 20.69% in 2024, then surged by 3,620bps to 16.91% in 2025.
  • Its Tax Rate was 16.91% in Q3 2025, compared to 56.81% in Q2 2025 and 15.40% in Q1 2025.